JFG
Jefferies Financial Group Portfolio holdings
AUM
$6.06B
1-Year Return
9.37%
This Quarter Return
+4.86%
1 Year Return
+9.37%
3 Year Return
+16.02%
5 Year Return
+51.04%
10 Year Return
+258.41%
AUM
$6.37B
AUM Growth
+$2.36B
(+59%)
Cap. Flow
+$1.67B
Cap. Flow
% of AUM
26.17%
Top 10 Holdings %
Top 10 Hldgs %
35.37%
Holding
1,607
New
410
Increased
344
Reduced
245
Closed
294
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$942M |
| 2 |
Surgery Partners
SGRY
|
+$145M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$89.5M |
| 4 |
LCA
Landcadia Holdings IV, Inc. Class A Common Stock
LCA
|
+$65M |
| 5 |
Invesco Zacks Mid-Cap ETF
CZA
|
+$52.5M |
Top Sells
| 1 |
SPDR S&P Biotech ETF
XBI
|
+$72.5M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$71.9M |
| 3 |
FRGI
Fiesta Restaurant Group, Inc.
FRGI
|
+$44.5M |
| 4 |
Apple
AAPL
|
+$43.8M |
| 5 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$37.1M |
Sector Composition
| 1 | Healthcare | 15.25% |
| 2 | Technology | 9.64% |
| 3 | Industrials | 6.63% |
| 4 | Financials | 5.96% |
| 5 | Consumer Discretionary | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
701
Bio-Rad Laboratories Class A
BIO
$7.64B
| $646K | ﹤0.01% |
2,000
+1,265
| +172% | +$408K |
|
702
Hanesbrands
HBI
$2.21B
| $646K | ﹤0.01% |
144,732
+117,623
| +434% | +$525K |
|
|
GOL
703
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
| $643K | ﹤0.01% |
177,549
| – | – |
|
704
Agilent Technologies
A
$35.6B
| $640K | ﹤0.01% |
4,600
-30,531
| -87% | -$4.24M |
|
705
MoonLake Immunotherapeutics
MLTX
$3.56B
| $639K | ﹤0.01% |
+10,575
| New | +$639K |
|
706
Krystal Biotech
KRYS
$3.98B
| $637K | ﹤0.01% |
+5,138
| New | +$637K |
|
707
Appian
APPN
$2.33B
| $636K | ﹤0.01% |
+16,881
| New | +$636K |
|
708
Keros Therapeutics
KROS
$621M
| $632K | ﹤0.01% |
+15,900
| New | +$632K |
|
709
WSFS Financial
WSFS
$3.18B
| $632K | ﹤0.01% |
+13,750
| New | +$632K |
|
710
Armstrong World Industries
AWI
$8.47B
| $629K | ﹤0.01% |
+6,400
| New | +$629K |
|
711
Plexus
PLXS
$3.7B
| $629K | ﹤0.01% |
+5,815
| New | +$629K |
|
712
Graphic Packaging
GPK
$6.08B
| $627K | ﹤0.01% |
25,440
-4,560
| -15% | -$112K |
|
713
Verisk Analytics
VRSK
$36.7B
| $624K | ﹤0.01% |
2,612
-47
| -2% | -$11.2K |
|
714
IDEAYA Biosciences
IDYA
$2.2B
| $623K | ﹤0.01% |
+17,500
| New | +$623K |
|
|
EGRX
715
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $622K | ﹤0.01% |
+118,857
| New | +$622K |
|
716
Vanguard Mid-Cap Growth ETF
VOT
$17.8B
| $621K | ﹤0.01% |
+2,830
| New | +$621K |
|
717
Verint Systems
VRNT
$1.23B
| $611K | ﹤0.01% |
+22,610
| New | +$611K |
|
718
Kymera Therapeutics
KYMR
$3.13B
| $611K | ﹤0.01% |
24,000
-940
| -4% | -$23.9K |
|
719
Halozyme
HALO
$8.84B
| $610K | ﹤0.01% |
+16,504
| New | +$610K |
|
720
Wynn Resorts
WYNN
$12.8B
| $609K | ﹤0.01% |
+6,682
| New | +$609K |
|
721
HNI Corp
HNI
$2.06B
| $607K | ﹤0.01% |
+14,520
| New | +$607K |
|
722
Macerich
MAC
$4.57B
| $607K | ﹤0.01% |
39,349
+20,571
| +110% | +$317K |
|
723
Roku
ROKU
$13.8B
| $606K | ﹤0.01% |
+6,610
| New | +$606K |
|
724
First Horizon
FHN
$11.5B
| $603K | ﹤0.01% |
42,554
-103,446
| -71% | -$1.46M |
|
725
iShares Silver Trust
SLV
$20.2B
| $601K | ﹤0.01% |
27,599
-76,525
| -73% | -$1.67M |
|